InMed Pharmaceuticals Inc (INM)

[Aladdin80]

**Financing** Anyone following this company/investment closely understands that they will need another round of financing by or before the summer. One thing I don't understand is how so many people can scream that this is such a great price to add to right now when they're literally staring down another round of financing at horrendous SP levels. From their own MD&A filing in Dec "The ability for the Company to materially develop its research and development programs beyond the end of our current fiscal year (June) is subject to the raising of additional capital."

Given that they have no drug candidates mature enough to generate a partnership investment from pharma rule that path out. Given that they earlier said bioinformatics is not currently licensable one can also rule that path to revenue out. Biosynthesis will be lucky to be online by the end of the calendar yr. That means expect really dilutive financing to get through current R&D efforts. Better to wait this out.